OptiNose, Inc.OptiNose, Inc.OptiNose, Inc.

OptiNose, Inc.

No trades
See on Supercharts
Market capitalization
‪104.51 M‬USD
‪−35.48 M‬USD
‪70.99 M‬USD
‪80.41 M‬
Beta (1Y)

About OptiNose, Inc.

Ramy A. Mahmoud
Employees (FY)
OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of OPTN is 0.8942 USD — it has decreased by 3.61% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange OptiNose, Inc. stocks are traded under the ticker OPTN.
OptiNose, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
OPTN stock is 7.97% volatile and has beta coefficient of −0.07. Check out the list of the most volatile stocks — is OptiNose, Inc. there?
One year price forecast for OptiNose, Inc. has a max estimate of 5.0000 USD and a min estimate of 3.0000 USD.
OPTN earnings for the last quarter are −0.08 USD per share, whereas the estimation was −0.09 USD resulting in a 15.21% surprise. The estimated earnings for the next quarter are −0.09 USD per share. See more details about OptiNose, Inc. earnings.
OptiNose, Inc. revenue for the last quarter amounts to ‪19.82 M‬ USD despite the estimated figure of ‪18.68 M‬ USD. In the next quarter revenue is expected to reach ‪19.26 M‬ USD.
Yes, you can track OptiNose, Inc. financials in yearly and quarterly reports right on TradingView.
OPTN stock has fallen by 27.89% compared to the previous week, the month change is a 48.31% fall, over the last year OptiNose, Inc. has showed a 54.38% decrease.
OPTN net income for the last quarter is ‪−9.97 M‬ USD, while the quarter before that showed ‪−9.29 M‬ USD of net income which accounts for −7.24% change. Track more OptiNose, Inc. financial stats to get the full picture.
Today OptiNose, Inc. has the market capitalization of ‪104.51 M‬, it has decreased by 5.67% over the last week.
No, OPTN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OPTN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OptiNose, Inc. stock right from TradingView charts — choose your broker and connect to your account.
OPTN reached its all-time high on Jul 9, 2018 with the price of 30.0000 USD, and its all-time low was 0.9000 USD and was reached on Jul 17, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 132.00 employees. See our rating of the largest employees — is OptiNose, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OptiNose, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OptiNose, Inc. stock shows the sell signal. See more of OptiNose, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on OptiNose, Inc. future price: according to them, OPTN price has a max estimate of 5.00 USD and a min estimate of 3.00 USD. Read a more detailed OptiNose, Inc. forecast: see what analysts think of OptiNose, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OptiNose, Inc. EBITDA is ‪−22.35 M‬ USD, and current EBITDA margin is −31.48%. See more stats in OptiNose, Inc. financial statements.